Quest Partners LLC Recursion Pharmaceuticals, Inc. Transaction History

Quest Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$5.92 - $8.6 $86,278 - $125,336	-14,574 Reduced 60.18%	9,645 $63.6 Million
Q2 2024 Aug 06, 2024	BUY	$7.35 - $10.05 $61,379 - $83,927	8,351 Added 52.63%	24,219 $182 Million
Q1 2024 May 09, 2024	SELL	$9.13 - $15.52 $34,694 - $58,976	-3,800 Reduced 19.32%	15,868 $158 Million
Q4 2023 Feb 09, 2024	BUY	$5.09 - $10.79 $100,110 - $212,217	19,668 New	19,668 $194 Million

340

285M

2.83M

3.64M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $994M
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Quest Partners LLC with notifications on news.